American Association for Cancer Research

Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy

Bookmark and Share

Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy 2011 - The stroma of some tumors can adopt lymphoid-like features including markers for high endothelial venules (LYVE1:red, CD31: green, pNAD: white, Nuclei:blue), which are specialized vessels designed for T cell entry into the lymph node where they can be primed. Photo by Amanda W. Lund from Conference Co-Chairperson, Melody Swartz’s lab

Tumor Microenvironment Complexity:
Emerging Roles in Cancer Therapy
November 3-6, 2011
Hilton Orlando Hotel
Orlando, FL

CONFERENCE CO-CHAIRPERSONS:
Lisa M. Coussens, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA
Yves A. DeClerck, University of Southern California / Children's Hospital, Los Angeles, CA
Melody Swartz, Swiss Federal Institute of Technology, Lausanne, Switzerland

This conference, presented in conjunction with the Tumor Microenvironment Working Group of the AACR, provided a fresh glimpse into how aspects of tumor microenvironments regulate cancer initiation and progression through interactions between initiated cells, activated stromal cells and components of the extracellular matrix. Sessions covered significant findings in basic science and the therapeutic opportunities revealed by these new discoveries. Dr. Luis Parada of UT Southwestern Medical Center presented the opening keynote address and Dr. Michael Karin of University of California, San Diego, presented the closing keynote address. The conference also featured an NCI Workshop, Tumor Microenvironment Network (TMEN): Goals and Objectives presented by Dr. Suresh Mohla. Over 250 attendees participated in the conference with nearly half of attendees presenting posters of their latest work.

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.